文献速递皮肤肿瘤

极薄浸润性黑色素瘤前哨淋巴结转移的预测因素

Predictors of sentinel lymph node metastasis in very thin invasive melanomas.
PubMed 文献 · Br J Dermatol · 2023-01-01

基于美国国家癌症数据库2012至2018年数据,分析Breslow厚度<0.8 mm黑色素瘤患者前哨淋巴结活检阳性预测因素。多变量分析显示淋巴血管侵犯(OR 4.5)、溃疡(OR 2.6)、核分裂(OR 2.1)和结节型(OR 2.1)与淋巴结阳性显著相关。前哨淋巴结阳性与阴性患者5年总生存率分别为75%和92%。

要点

  • 极薄黑色素瘤(Breslow<0.8 mm)前哨淋巴结阳性率为5.0%。
  • 淋巴血管侵犯、溃疡、核分裂和结节型与淋巴结阳性显著相关。
  • 前哨淋巴结阳性患者5年总生存率低于阴性患者(75% vs 92%)。

核心结论

  • 极薄黑色素瘤中淋巴结阳性具有预后意义,总体前哨淋巴结阳性率为5%。
  • 特定肿瘤因素(淋巴血管侵犯、溃疡、核分裂、结节型)与更高的前哨淋巴结转移率相关,应用于指导临床选择受益于前哨淋巴结活检的患者。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2012至2018年Breslow厚度<0.8 mm的黑色素瘤患者。
  • 排除溃疡状态或前哨淋巴结活检实施情况未知者。
  • 采用χ2检验和逻辑回归分析患者、肿瘤及卫生系统因素对前哨淋巴结阳性的影响,Kaplan-Meier法比较总生存。

主要发现

  • 接受前哨淋巴结活检的17 692例患者中,876例(5.0%)发现淋巴结阳性转移。
  • 多变量分析中与淋巴结阳性显著相关的因素:淋巴血管侵犯(OR 4.5,P<0.001)、溃疡(OR 2.6,P<0.001)、核分裂(OR 2.1,P<0.001)、结节型(OR 2.1,P<0.001)。
  • 前哨淋巴结阳性和阴性患者的5年总生存率分别为75%和92%。

关键数值与推荐

  • 淋巴血管侵犯:OR 4.5(P<0.001)。
  • 溃疡:OR 2.6(P<0.001)。
  • 核分裂:OR 2.1(P<0.001)。
  • 结节型:OR 2.1(P<0.001)。

临床怎么用

  • 临床可依据淋巴血管侵犯、溃疡、核分裂和结节型等肿瘤因素,选择可能从首次淋巴结活检中获益的极薄黑色素瘤患者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanomas < 0.8 mm in Breslow depth have less than a 5% risk for nodal positivity. Nonetheless, nodal positivity is prognostic for this group. Early identification of nodal positivity may improve the outcomes for these patients. OBJECTIVES: To determine the degree to which ulceration and other high-risk features predict sentinel lymph node (SLN) positivity for very thin melanomas. METHODS: The National Cancer Database was reviewed from 2012 to 2018 for patients with melanoma with Breslow thickness < 0.8 mm. Data were analysed from 7 July 2022 through to 25 February 2023. Patients were excluded if data regarding their ulceration status or SLN biopsy (SLNB) performance were unknown. We analysed patient, tumour and health system factors for their effect on SLN positivity. Data were analysed using χ2 tests and logistic regressions. Overall survival (OS) was compared by Kaplan-Meier analyses. RESULTS: Positive nodal metastases were seen in 876 (5.0%) patients who underwent SLNB (17 692). Factors significantly associated with nodal positivity on multivariable analysis include lymphovascular invasion [odds ratio (OR) 4.5, P < 0.001], ulceration (OR 2.6, P < 0.001), mitoses (OR 2.1, P < 0.001) and nodular subtype (OR 2.1, P < 0.001). Five-year OS was 75% and 92% for patients with positive and negative SLN, respectively. CONCLUSIONS: Nodal positivity has prognostic significance for very thin melanomas. In our cohort, the rate of nodal positivity was 5% overall in these patients who underwent SLNB. Specific tumour factors (e.g. lymphovascular invasion, ulceration, mitoses, nodular subtype) were associated with higher rates of SLN metastases and should be used to guide clinicians in choosing which patients will benefit from SLNB.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Kakish H, Sun J, Zheng DX, et al. Predictors of sentinel lymph node metastasis in very thin invasive melanomas. Br J Dermatol. 2023. PMID: 37290803. doi:10.1093/bjd/ljad195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。